Cargando…
Hepatic safety profile of pancreatic cancer‑bearing mice fed a ketogenic diet in combination with gemcitabine
Ketogenic diets (KDs) are actively being evaluated for their potential anticancer effects. Although KDs are generally considered safe, their safety profile when combined with chemotherapy remains unknown. It is known that a KD enhances the anticancer effect of gemcitabine (2′,2′-difluoro-2′-deoxycyt...
Autores principales: | Cortez, Natalia E., Lanzi, Cecilia Rodriguez, Vahmani, Payam, Matsukuma, Karen, Mackenzie, Gerardo G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561147/ https://www.ncbi.nlm.nih.gov/pubmed/37818128 http://dx.doi.org/10.3892/ol.2023.14067 |
Ejemplares similares
-
A Ketogenic Diet in Combination with Gemcitabine Increases Survival in Pancreatic Cancer KPC Mice
por: Cortez, Natalia E., et al.
Publicado: (2022) -
Correction: A Ketogenic Diet in Combination with Gemcitabine Increases Survival in Pancreatic Cancer KPC Mice
por: Cortez, Natalia E., et al.
Publicado: (2022) -
A Ketogenic Diet in Combination with Gemcitabine Mitigates Pancreatic Cancer-Associated Cachexia in Male and Female KPC Mice
por: Cortez, Natalia E., et al.
Publicado: (2023) -
Ketogenic Diets in Pancreatic Cancer and Associated Cachexia: Cellular Mechanisms and Clinical Perspectives
por: Cortez, Natalia E., et al.
Publicado: (2021) -
Data set for characterization of the glycosylation status of hepatic glycoproteins in mice fed a low-carbohydrate ketogenic diet
por: Okuda, Tetsuya
Publicado: (2019)